篮球赔率

篮球赔率 Services FAQ Contact Us 0
Home Pharmaceuticals Oncology Precision Medicine Market Size, Share, Growth Forecast by 2033
Oncology Precision Medicine Market

Oncology Precision Medicine Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics, Inhibitor drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-retroviral drugs), By Applications (Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Cervical cancer, Kideny Cancer, Liver Cancer, Bladder Cancer, Other applications), By Ecosystem IT Supports (Applied sciences, Precision diagnostics, Digital health and information technology, Precision therapeutics), By End Users (Hospitals, Diagnostics centres, Research and medical institutes, Homecare Settings) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRPH1850DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Oncology Precision Medicine Market Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Diagnostics
        1. By Value
      3. Therapeutics
        1. By Value
      4. Inhibitor drugs
        1. By Value
      5. Monoclonal Antibodies
        1. By Value
      6. Cell & Gene Therapy
        1. By Value
      7. Antiviral & Anti-retroviral drugs
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Breast cancer
        1. By Value
      3. Lung cancer
        1. By Value
      4. Colorectal cancer
        1. By Value
      5. Prostate cancer
        1. By Value
      6. Cervical cancer
        1. By Value
      7. Kideny Cancer
        1. By Value
      8. Liver Cancer
        1. By Value
      9. Bladder Cancer
        1. By Value
      10. Other applications
        1. By Value
    4. By Ecosystem IT Supports
      1. Introduction
        1. Ecosystem IT Supports By Value
      2. Applied sciences
        1. By Value
      3. Precision diagnostics
        1. By Value
      4. Digital health and information technology
        1. By Value
      5. Precision therapeutics
        1. By Value
    5. By End Users
      1. Introduction
        1. End Users By Value
      2. Hospitals
        1. By Value
      3. Diagnostics centres
        1. By Value
      4. Research and medical institutes
        1. By Value
      5. Homecare Settings
        1. By Value
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Diagnostics
        1. By Value
      3. Therapeutics
        1. By Value
      4. Inhibitor drugs
        1. By Value
      5. Monoclonal Antibodies
        1. By Value
      6. Cell & Gene Therapy
        1. By Value
      7. Antiviral & Anti-retroviral drugs
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Breast cancer
        1. By Value
      3. Lung cancer
        1. By Value
      4. Colorectal cancer
        1. By Value
      5. Prostate cancer
        1. By Value
      6. Cervical cancer
        1. By Value
      7. Kideny Cancer
        1. By Value
      8. Liver Cancer
        1. By Value
      9. Bladder Cancer
        1. By Value
      10. Other applications
        1. By Value
    4. By Ecosystem IT Supports
      1. Introduction
        1. Ecosystem IT Supports By Value
      2. Applied sciences
        1. By Value
      3. Precision diagnostics
        1. By Value
      4. Digital health and information technology
        1. By Value
      5. Precision therapeutics
        1. By Value
    5. By End Users
      1. Introduction
        1. End Users By Value
      2. Hospitals
        1. By Value
      3. Diagnostics centres
        1. By Value
      4. Research and medical institutes
        1. By Value
      5. Homecare Settings
        1. By Value
    6. U.S.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Diagnostics
          1. By Value
        3. Therapeutics
          1. By Value
        4. Inhibitor drugs
          1. By Value
        5. Monoclonal Antibodies
          1. By Value
        6. Cell & Gene Therapy
          1. By Value
        7. Antiviral & Anti-retroviral drugs
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Breast cancer
          1. By Value
        3. Lung cancer
          1. By Value
        4. Colorectal cancer
          1. By Value
        5. Prostate cancer
          1. By Value
        6. Cervical cancer
          1. By Value
        7. Kideny Cancer
          1. By Value
        8. Liver Cancer
          1. By Value
        9. Bladder Cancer
          1. By Value
        10. Other applications
          1. By Value
      3. By Ecosystem IT Supports
        1. Introduction
          1. Ecosystem IT Supports By Value
        2. Applied sciences
          1. By Value
        3. Precision diagnostics
          1. By Value
        4. Digital health and information technology
          1. By Value
        5. Precision therapeutics
          1. By Value
      4. By End Users
        1. Introduction
          1. End Users By Value
        2. Hospitals
          1. By Value
        3. Diagnostics centres
          1. By Value
        4. Research and medical institutes
          1. By Value
        5. Homecare Settings
          1. By Value
    7. Canada
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Diagnostics
        1. By Value
      3. Therapeutics
        1. By Value
      4. Inhibitor drugs
        1. By Value
      5. Monoclonal Antibodies
        1. By Value
      6. Cell & Gene Therapy
        1. By Value
      7. Antiviral & Anti-retroviral drugs
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Breast cancer
        1. By Value
      3. Lung cancer
        1. By Value
      4. Colorectal cancer
        1. By Value
      5. Prostate cancer
        1. By Value
      6. Cervical cancer
        1. By Value
      7. Kideny Cancer
        1. By Value
      8. Liver Cancer
        1. By Value
      9. Bladder Cancer
        1. By Value
      10. Other applications
        1. By Value
    4. By Ecosystem IT Supports
      1. Introduction
        1. Ecosystem IT Supports By Value
      2. Applied sciences
        1. By Value
      3. Precision diagnostics
        1. By Value
      4. Digital health and information technology
        1. By Value
      5. Precision therapeutics
        1. By Value
    5. By End Users
      1. Introduction
        1. End Users By Value
      2. Hospitals
        1. By Value
      3. Diagnostics centres
        1. By Value
      4. Research and medical institutes
        1. By Value
      5. Homecare Settings
        1. By Value
    6. U.K.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Diagnostics
          1. By Value
        3. Therapeutics
          1. By Value
        4. Inhibitor drugs
          1. By Value
        5. Monoclonal Antibodies
          1. By Value
        6. Cell & Gene Therapy
          1. By Value
        7. Antiviral & Anti-retroviral drugs
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Breast cancer
          1. By Value
        3. Lung cancer
          1. By Value
        4. Colorectal cancer
          1. By Value
        5. Prostate cancer
          1. By Value
        6. Cervical cancer
          1. By Value
        7. Kideny Cancer
          1. By Value
        8. Liver Cancer
          1. By Value
        9. Bladder Cancer
          1. By Value
        10. Other applications
          1. By Value
      3. By Ecosystem IT Supports
        1. Introduction
          1. Ecosystem IT Supports By Value
        2. Applied sciences
          1. By Value
        3. Precision diagnostics
          1. By Value
        4. Digital health and information technology
          1. By Value
        5. Precision therapeutics
          1. By Value
      4. By End Users
        1. Introduction
          1. End Users By Value
        2. Hospitals
          1. By Value
        3. Diagnostics centres
          1. By Value
        4. Research and medical institutes
          1. By Value
        5. Homecare Settings
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Diagnostics
        1. By Value
      3. Therapeutics
        1. By Value
      4. Inhibitor drugs
        1. By Value
      5. Monoclonal Antibodies
        1. By Value
      6. Cell & Gene Therapy
        1. By Value
      7. Antiviral & Anti-retroviral drugs
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Breast cancer
        1. By Value
      3. Lung cancer
        1. By Value
      4. Colorectal cancer
        1. By Value
      5. Prostate cancer
        1. By Value
      6. Cervical cancer
        1. By Value
      7. Kideny Cancer
        1. By Value
      8. Liver Cancer
        1. By Value
      9. Bladder Cancer
        1. By Value
      10. Other applications
        1. By Value
    4. By Ecosystem IT Supports
      1. Introduction
        1. Ecosystem IT Supports By Value
      2. Applied sciences
        1. By Value
      3. Precision diagnostics
        1. By Value
      4. Digital health and information technology
        1. By Value
      5. Precision therapeutics
        1. By Value
    5. By End Users
      1. Introduction
        1. End Users By Value
      2. Hospitals
        1. By Value
      3. Diagnostics centres
        1. By Value
      4. Research and medical institutes
        1. By Value
      5. Homecare Settings
        1. By Value
    6. China
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Diagnostics
          1. By Value
        3. Therapeutics
          1. By Value
        4. Inhibitor drugs
          1. By Value
        5. Monoclonal Antibodies
          1. By Value
        6. Cell & Gene Therapy
          1. By Value
        7. Antiviral & Anti-retroviral drugs
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Breast cancer
          1. By Value
        3. Lung cancer
          1. By Value
        4. Colorectal cancer
          1. By Value
        5. Prostate cancer
          1. By Value
        6. Cervical cancer
          1. By Value
        7. Kideny Cancer
          1. By Value
        8. Liver Cancer
          1. By Value
        9. Bladder Cancer
          1. By Value
        10. Other applications
          1. By Value
      3. By Ecosystem IT Supports
        1. Introduction
          1. Ecosystem IT Supports By Value
        2. Applied sciences
          1. By Value
        3. Precision diagnostics
          1. By Value
        4. Digital health and information technology
          1. By Value
        5. Precision therapeutics
          1. By Value
      4. By End Users
        1. Introduction
          1. End Users By Value
        2. Hospitals
          1. By Value
        3. Diagnostics centres
          1. By Value
        4. Research and medical institutes
          1. By Value
        5. Homecare Settings
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Diagnostics
        1. By Value
      3. Therapeutics
        1. By Value
      4. Inhibitor drugs
        1. By Value
      5. Monoclonal Antibodies
        1. By Value
      6. Cell & Gene Therapy
        1. By Value
      7. Antiviral & Anti-retroviral drugs
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Breast cancer
        1. By Value
      3. Lung cancer
        1. By Value
      4. Colorectal cancer
        1. By Value
      5. Prostate cancer
        1. By Value
      6. Cervical cancer
        1. By Value
      7. Kideny Cancer
        1. By Value
      8. Liver Cancer
        1. By Value
      9. Bladder Cancer
        1. By Value
      10. Other applications
        1. By Value
    4. By Ecosystem IT Supports
      1. Introduction
        1. Ecosystem IT Supports By Value
      2. Applied sciences
        1. By Value
      3. Precision diagnostics
        1. By Value
      4. Digital health and information technology
        1. By Value
      5. Precision therapeutics
        1. By Value
    5. By End Users
      1. Introduction
        1. End Users By Value
      2. Hospitals
        1. By Value
      3. Diagnostics centres
        1. By Value
      4. Research and medical institutes
        1. By Value
      5. Homecare Settings
        1. By Value
    6. UAE
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Diagnostics
          1. By Value
        3. Therapeutics
          1. By Value
        4. Inhibitor drugs
          1. By Value
        5. Monoclonal Antibodies
          1. By Value
        6. Cell & Gene Therapy
          1. By Value
        7. Antiviral & Anti-retroviral drugs
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Breast cancer
          1. By Value
        3. Lung cancer
          1. By Value
        4. Colorectal cancer
          1. By Value
        5. Prostate cancer
          1. By Value
        6. Cervical cancer
          1. By Value
        7. Kideny Cancer
          1. By Value
        8. Liver Cancer
          1. By Value
        9. Bladder Cancer
          1. By Value
        10. Other applications
          1. By Value
      3. By Ecosystem IT Supports
        1. Introduction
          1. Ecosystem IT Supports By Value
        2. Applied sciences
          1. By Value
        3. Precision diagnostics
          1. By Value
        4. Digital health and information technology
          1. By Value
        5. Precision therapeutics
          1. By Value
      4. By End Users
        1. Introduction
          1. End Users By Value
        2. Hospitals
          1. By Value
        3. Diagnostics centres
          1. By Value
        4. Research and medical institutes
          1. By Value
        5. Homecare Settings
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Diagnostics
        1. By Value
      3. Therapeutics
        1. By Value
      4. Inhibitor drugs
        1. By Value
      5. Monoclonal Antibodies
        1. By Value
      6. Cell & Gene Therapy
        1. By Value
      7. Antiviral & Anti-retroviral drugs
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Breast cancer
        1. By Value
      3. Lung cancer
        1. By Value
      4. Colorectal cancer
        1. By Value
      5. Prostate cancer
        1. By Value
      6. Cervical cancer
        1. By Value
      7. Kideny Cancer
        1. By Value
      8. Liver Cancer
        1. By Value
      9. Bladder Cancer
        1. By Value
      10. Other applications
        1. By Value
    4. By Ecosystem IT Supports
      1. Introduction
        1. Ecosystem IT Supports By Value
      2. Applied sciences
        1. By Value
      3. Precision diagnostics
        1. By Value
      4. Digital health and information technology
        1. By Value
      5. Precision therapeutics
        1. By Value
    5. By End Users
      1. Introduction
        1. End Users By Value
      2. Hospitals
        1. By Value
      3. Diagnostics centres
        1. By Value
      4. Research and medical institutes
        1. By Value
      5. Homecare Settings
        1. By Value
    6. Brazil
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Diagnostics
          1. By Value
        3. Therapeutics
          1. By Value
        4. Inhibitor drugs
          1. By Value
        5. Monoclonal Antibodies
          1. By Value
        6. Cell & Gene Therapy
          1. By Value
        7. Antiviral & Anti-retroviral drugs
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Breast cancer
          1. By Value
        3. Lung cancer
          1. By Value
        4. Colorectal cancer
          1. By Value
        5. Prostate cancer
          1. By Value
        6. Cervical cancer
          1. By Value
        7. Kideny Cancer
          1. By Value
        8. Liver Cancer
          1. By Value
        9. Bladder Cancer
          1. By Value
        10. Other applications
          1. By Value
      3. By Ecosystem IT Supports
        1. Introduction
          1. Ecosystem IT Supports By Value
        2. Applied sciences
          1. By Value
        3. Precision diagnostics
          1. By Value
        4. Digital health and information technology
          1. By Value
        5. Precision therapeutics
          1. By Value
      4. By End Users
        1. Introduction
          1. End Users By Value
        2. Hospitals
          1. By Value
        3. Diagnostics centres
          1. By Value
        4. Research and medical institutes
          1. By Value
        5. Homecare Settings
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Oncology Precision Medicine Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. F Hoffmann-La Roche AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Invitae Corporation
    3. Illumina Inc.
    4. Thermo Fisher Scientific Inc.
    5. QIAGEN
    6. Quest Diagnostics
    7. Laboratory Corporation of America Holdings
    8. Novartis AG
    9. AstraZeneca
    10. Bristol-Myers Squibb
    11. Eli Lilly
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Precision Medicine Market Size The global precision medicine market size was valued at USD 99.88 billion in 2024 and is projected to reach from USD 115.76 billion in 2025 to USD 376.91 billion by 2033, growing at a CAGR of 15.90% during the forecast
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

篮球赔率
漏 Copyright . All rights Reserved.